HOME
WHO IS BDA
BDA DELIVERS
KEY PROJECTS
REFERENCE WORK 
PRINCIPALS & ASSOCIATES
CONTACT US 
Business Development Advisors
Reference Work

Intratherapeutics [ITI previously CardiaCatheter] develops, manufactures and markets a line of medical devices for the diagnosis and treatment of peripheral vascular disease and relief of non-vascular obstructions. ITI has the CE Mark on several peripheral vascular stents for use in treating strictures in the iliac, renal, femoral and popliteal and subclavian arteries, and on non-vascular stents for treating strictures in the biliary ducts, bronchial tract, esophagus, and colorectal obstructions. The Company has attained FDA 510(k) market clearance for non-vascular stent use in the biliary duct, bronchial tract and esophagus. IntraTherapeutics also has CE Mark and 510(k) market clearance for its highly differentiated guiding catheter. ITI was sold to Sulzer-Medica in March 2001.

How Sourced: Founders & Board members

Our involvement: Lead business reorganization, recreation of business plan, management, fundraising bplan, offering docs, negotiate out of strategic alliance, into new business relations, mgmt, fundraising